TDS Pharm Co (XKRX:464280) Total Operating Expense: ₩3,567 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:464280 TDS Pharm Co Ltd XKRX:464280
40 GF Score
Price ₩5,520.00
! 1 Warning Sign
View Full Analysis

What is TDS Pharm Co Total Operating Expense?

TDS Pharm Co XKRX:464280 40 Total Operating Expense is ₩3,567 Mil as of Jun. 2026. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review.

TDS Pharm Co's Total Operating Expense for the three months ended in Jun. 2026 was ₩865 Mil. TDS Pharm Co's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₩3,567 Mil.

TDS Pharm Co Total Operating Expense Related Terms

TDS Pharm Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for TDS Pharm Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TDS Pharm Co Total Operating Expense Chart

TDS Pharm Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 1,672.28 2,386.05 2,924.70 3,992.26 3,738.50

TDS Pharm Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 978.37 908.17 863.78 930.46 864.95
XKRX:464280
40GF Score
TDS Pharm Co Ltd XKRX:464280
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TDS Pharm Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,567 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₩3,567 Mil mean?
TDS Pharm Co (XKRX:464280) has a Total Operating Expense of ₩3,567 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on TDS Pharm Co and its competitors.
Is TDS Pharm Co's Total Operating Expense too high?
TDS Pharm Co's current Total Operating Expense is ₩3,567 Mil. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Total Operating Expense compare to LLY and JNJ?
TDS Pharm Co's Total Operating Expense of ₩3,567 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on TDS Pharm Co and its competitors. TDS Pharm Co's current Total Operating Expense is ₩3,567 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Total Operating Expense of ₩3,567 Mil. The current Total Operating Expense is ₩3,567 Mil. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Total Operating Expense is ₩3,567 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TDS Pharm Co Business Description

Address 253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score

Get the complete analysis for XKRX:464280

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩5,520.00
Price